Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-09
DOI
10.1038/s41598-018-28849-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
- (2016) Tomoya Mita et al. DIABETES CARE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
- (2015) Tomoya Mita et al. DIABETES CARE
- Role of Pancreatic Transcription Factors in Maintenance of Mature β-Cell Function
- (2015) Hideaki Kaneto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass
- (2014) Ryan K. Mitchell et al. HUMAN MOLECULAR GENETICS
- Incretin hormones and the satiation signal
- (2013) J J Holst INTERNATIONAL JOURNAL OF OBESITY
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury
- (2012) Yoichiro Hirata et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
- (2011) Hiromasa Goto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- TCF7L2 Regulates Late Events in Insulin Secretion From Pancreatic Islet -Cells
- (2009) G. da Silva Xavier et al. DIABETES
- Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
- (2009) Luan Shu et al. HUMAN MOLECULAR GENETICS
- A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
- (2009) Hongbin Liu et al. JOURNAL OF ENDOCRINOLOGY
- GLP-1: physiological effects and potential therapeutic applications
- (2008) Kasper Aaboe et al. DIABETES OBESITY & METABOLISM
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Glucagon-like peptide-1, glucose homeostasis and diabetes
- (2008) Jens J. Holst et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started